CERO THERAPEUTICS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (CERO) Institutional Ownership

Q: What is CUSIP 71902K303?

CUSIP 71902K303 is the security identifier used in SEC filing datasets for CERO - CERO THERAPEUTICS HOLDINGS, INC. - Common Stock, par value $0.0001 per share.

Q: Who owns CERO - CERO THERAPEUTICS HOLDINGS, INC. - Common Stock, par value $0.0001 per share based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

CUSIP: 71902K303

13F Institutional Holders and Ownership History from Q4 2024 to Q2 2025

Type / Class: Equity / Common Stock, par value $0.0001 per share
Symbol: CERO on Nasdaq
Shares outstanding: 5,851,331
Price per share: $0.37

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 71902K303?
CUSIP 71902K303 identifies CERO - CERO THERAPEUTICS HOLDINGS, INC. - Common Stock, par value $0.0001 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 71902K303:

Q2 2025 (0 holders) Q1 2025 (13 holders) Q4 2024 (1 holder)

Significant Owners of CERO THERAPEUTICS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (CERO) based on Schedule 13D/G filings

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
ARMISTICE CAPITAL, LLC	10%		$555,321		584,548		Armistice Capital, LLC	31 Mar 2025

Institutional Holders of CERO THERAPEUTICS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (CERO) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Price (Median)	Investors
2025 Q2	0	$0	-$527,597	$0.37	0
2025 Q1	722,739	$527,597	+$523,580	$0.73	13
2024 Q4	5,523	$331		$0.06	1